Overview
1. Executive Summary (Confidence: High)
Sleepiz AG is at the forefront of the shift from "wired and wearable" to "completely wireless" standards of care. Based in Zurich with a global footprint in Germany, the US, and India, the company has developed the Sleepiz One+, a CE-marked Class IIa and FDA 510(k) cleared device. By utilizing sub-millimeter accurate radar technology, Sleepiz can capture heart and respiration rates with medical-grade precision from a bedside table. Its strategic partnership with Clario to integrate sleep endpoints into clinical trials highlights its growing influence in decentralized healthcare. With over CHF 6 million in total Series A funding, the organization is now scaling its remote patient monitoring (RPM) services in the US market.
This public view only shows an extract. Open the full profile to access the complete company intelligence record, including the full write-up and structured research details.